ARTICLES BY THIS AUTHOR
- 8/31/2011
Drug News: September 2011
Benlysta: new IV immunosuppressant for SLE; Brilinta: new antiplatelet agent for prevention of CV events after ACS. - 8/31/2011
Adverse Reactions: Long-term safety of PPIs
Two recent publications highlight the long-term safety of these medications, specifically concerning the development of hypomagnesemia and the increased risk of bone fractures. - 8/31/2011
Ontario adds more paid pharmacy services
Pharmacists can now claim reimbursement for smoking cessation counselling and pharmaceutical opinions. - 8/31/2011
Ontario CMPA fees to drop 54% next year
Decrease due to pressure from Ontario government but doctors call it ‘cash grab’ that will undermine reserve - 8/30/2011
Using multimedia for patient education
Developing education tools and helping patients navigate online health information. - 8/30/2011
Saving green by going green at the Mazankowski
More than $1 million a year is going back into patient care thanks to the environmentally friendly design of the Mazankowski Alberta Heart Institute. - 8/30/2011
Kevin Smith named supervisor for Niagara Health System
The Ontario government has appointed Dr. Kevin Smith as supervisor for Niagara Health System. On Aug. 15, Health Minister Deb Matthews recommended to cabinet that a provincial supervisor be appointed to the troubled health system—the largest in the province—which had come under fire for a dangerous outbreak of C. difficile. - 8/30/2011
Moose Jaw to get new hospital
Moose Jaw will soon be home to an innovative new regional hospital that will enable better, safer service for the city and surrounding area, says Don McMorris, Saskatchewan’s health minister. The new building will replace Moose Jaw Union Hospital. - 8/30/2011
IMGs sue N.B. regulator over licence terminology
College of physicians and surgeons says change not meant to stop them from moving from province - 8/30/2011
Study of C. difficile toxins may lead to new therapies
U.S. researchers have discovered how cells in the gut neutralize toxins produced by Clostridium difficile (C. difficile), a finding that may eventually lead to new methods of treatment.